Toll-like 4 receptor inhibitor TAK-242 decreases neuroinflammation in rat brain frontal cortex after stress.
Toll-like 4 receptor inhibitor TAK-242 decreases neuroinflammation in rat brain frontal cortex after stress.
复制标题
DOI:
10.1186/1742-2094-11-8
复制
发表时间:
2014-01-11
影响因子:
9.3
通讯作者:
Leza JC
中科院分区:
文献类型:
--
作者:
Gárate I;García-Bueno B;Madrigal JL;Caso JR;Alou L;Gómez-Lus ML;Leza JC
The innate immune response is the first line of defence against invading microorganisms and it is also activated in different neurologic/neurodegenerative pathological scenarios. As a result, the family of the innate immune toll-like receptors (TLRs) and, in particular, the genetic/pharmacological manipulation of the TLR-4 signalling pathway emerges as a potential therapeutic strategy. Growing evidence relates stress exposure with altered immune responses, but the precise role of TLR-4 remains partly unknown. The present study aimed to elucidate whether the elements of the TLR-4 signalling pathway are activated after acute stress exposure in rat brain frontal cortex and its role in the regulation of the stress-induced neuroinflammatory response, by means of its pharmacological modulation with the intravenous administration of the TLR-4 specific inhibitor TAK-242. Considering that TLR-4 responds predominantly to lipopolysaccharide from gram-negative bacteria, we checked whether increased intestinal permeability and a resultant bacterial translocation is a potential regulatory mechanism of stress-induced TLR-4 activation. Acute restraint stress exposure upregulates TLR-4 expression both at the mRNA and protein level. Stress-induced TLR-4 upregulation is prevented by the protocol of antibiotic intestinal decontamination made to reduce indigenous gastrointestinal microflora, suggesting a role for bacterial translocation on TLR-4 signalling pathway activation. TAK-242 pre-stress administration prevents the accumulation of potentially deleterious inflammatory and oxidative/nitrosative mediators in the brain frontal cortex of rats. The use of TAK-242 or other TLR-4 signalling pathway inhibitory compounds could be considered as a potential therapeutic adjuvant strategy to constrain the inflammatory process taking place after stress exposure and in stress-related neuropsychiatric diseases.
登录
查看更多内容
DOI:
10.1152/ajpgi.00328.2004
发表时间:
2005-05-01
影响因子:
4.5
作者:
Fukata, M;Michelsen, KS;Abreu, MT
通讯作者:
Abreu, MT
DOI:
10.1016/0885-4505(87)90035-1
发表时间:
1987-04-01
期刊:
BIOCHEMICAL MEDICINE AND METABOLIC BIOLOGY
影响因子:
--
作者:
DAS, NP;RATTY, AK
通讯作者:
RATTY, AK
影响因子:
15.1
作者:
Fleshner, Monika
通讯作者:
Fleshner, Monika
影响因子:
5
作者:
Kawamoto, Tomohiro;Ii, Masayuki;Kimura, Hiroyuki
通讯作者:
Kimura, Hiroyuki
影响因子:
2
作者:
Griffiths MR;Gasque P;Neal JW
通讯作者:
Neal JW